Sign In
Buy BCC
$76.38
+1.00 (+1.33%)
At Close: Jul 31, 2026
The Coiled Spring I'm Betting On - My Top Picks For America's Next Housing Boom
07:30am, Saturday, 25'th Oct 2025
The U.S. housing market is a 'coiled spring' with pent-up demand, poised for explosive growth if mortgage rates and regulations ease. Even small drops in mortgage rates have triggered surges in refina
James Hardie and Boise Cascade Company Announce Expanded Distribution Partnership
10:00am, Thursday, 23'rd Oct 2025
CHICAGO , Oct. 23, 2025 /PRNewswire/ -- James Hardie Building Products Inc., a subsidiary of James Hardie Industries plc (NYSE / ASX: JHX) ("James Hardie" or the "Company"), the North American leader
CLEVELAND CLINIC ABU DHABI (CCAD) IS THE PRINCIPAL INVESTIGATOR IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PA / ACCESS Newswire / October 22, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the
Boise Cascade Company Third Quarter 2025 Earnings Webcast and Conference Call
04:15pm, Tuesday, 21'st Oct 2025
BOISE, Idaho--(BUSINESS WIRE)--Boise Cascade Company (NYSE: BCC) will host a webcast and conference call to discuss 2025 third quarter earnings on Tuesday, November 4, 2025, at 11 a.m. Eastern. To joi
Brokerages Set Boise Cascade, L.L.C. (NYSE:BCC) Target Price at $103.33
01:30am, Monday, 20'th Oct 2025
Boise Cascade, L.L.C. (NYSE: BCC - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight brokerages that are presently covering the stock, Marketbeat.com repor
MCP Turns One: What It Means for AI and Your Business: BCC Research Webinar
06:06pm, Thursday, 16'th Oct 2025
Boston, Oct. 16, 2025 (GLOBE NEWSWIRE) -- One year after the introduction of the Model Context Protocol (MCP), organizations worldwide are rethinking how AI interacts with data. MCP - a framework that
WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin disease
Is the Options Market Predicting a Spike in Boise Cascade Stock?
10:01am, Thursday, 11'th Sep 2025
Investors need to pay close attention to BCC stock based on the movements in the options market lately.
Medicus Pharma begins Phase 2 clinical study in UAE to treat BCC
09:03am, Monday, 08'th Sep 2025
Medicus Pharma (NASDAQ:MDCX) announced that its SKNJCT-004 Phase 2 clinical study, a non-invasive treatment for Basal Cell Carcinoma (BCC) of the skin, has begun patient recruitment in Clevel
CLEVELAND CLINIC ABU DHABI (CCAD) HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 8, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus"
US Food and Drug Administration (FDA) has accepted the company's Type C meeting request and SKNJCT-003 Phase 2 study has randomized more than 75% of patients Philadelphia, Pennsylvania--(Newsfile Corp
I Am Bullish About Boise Cascade: Robots In Wood Processing
03:18am, Thursday, 21'st Aug 2025
Boise Cascade's integration of AI and robotics could drive significant efficiency and EBITDA margin improvements, setting it apart from smaller competitors. The company's integrated production and dis
Koninklijke Philips N.V. Profile: BCC Research Releases Comprehensive 360° Company Analysis
10:57am, Tuesday, 19'th Aug 2025
“An In-Depth Strategic Profile of Koninklijke Philips N.V.: Innovation, Global Expansion, and Long-Term Impact” “An In-Depth Strategic Profile of Koninklijke Philips N.V.: Innovation, Global Exp
Boise Cascade Company (BCC) Q2 2025 Earnings Call Transcript
02:02pm, Tuesday, 05'th Aug 2025
Boise Cascade Company (NYSE:BCC ) Q2 2025 Earnings Conference Call August 5, 2025 11:00 AM ET Company Participants Chris Forrey - Vice President of Finance & Investor Relations Joanna Barney - Executi
Boise Cascade (BCC) Q2 EPS Drops 42%
11:46am, Tuesday, 05'th Aug 2025
Boise Cascade (BCC) Q2 EPS Drops 42%
